Belotecan/cisplatin versus etoposide/cisplatin in previously untreated patients with extensive-stage small cell lung carcinoma: a multi-center randomized phase III trial

被引：0
|
作者：
In-Jae Oh
Kyu-Sik Kim
Cheol-Kyu Park
Young-Chul Kim
Kwan-Ho Lee
Jin-Hong Jeong
Sun-Young Kim
Jeong-Eun Lee
Kye-Chul Shin
Tae-Won Jang
Hyun-Kyung Lee
Kye-Young Lee
Sung-Yong Lee
机构：
[1] Chonnam National University Hwasun Hospital,Department of Internal Medicine, Lung and Esophageal Cancer Clinic
[2] Yeungnam University Medical Center,Department of Internal Medicine
[3] Yeungnam University College of Medicine,Department of Internal Medicine
[4] Chungnam National University Hospital,Department of Internal Medicine
[5] Chungnam National University School of Medicine,Department of Internal Medicine
[6] Yonsei University Wonju Severance Christian Hospital,Department of Internal Medicine
[7] Yonsei University College of Medicine,Department of Internal Medicine
[8] Kosin University Gospel Hospital,Department of Internal Medicine
[9] Kosin University College of Medicine,undefined
[10] Inje University Busan Paik Hospital,undefined
[11] Konkuk University Medical Center,undefined
[12] Konkuk University School of Medicine,undefined
[13] Guro Hospital,undefined
[14] Korea University,undefined
来源：
BMC Cancer | / 16卷
关键词：
Small cell lung carcinoma; Extensive stage disease; Phase III study; Chemotherapy; First-line; Belotecan;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer
    Reck, Martin
    Luft, Alexander
    Szczesna, Aleksandra
    Havel, Libor
    Kim, Sang-We
    Akerley, Wallace
    Pietanza, Maria Catherine
    Wu, Yi-long
    Zielinski, Christoph
    Thomas, Michael
    Felip, Enriqueta
    Gold, Kathryn
    Horn, Leora
    Aerts, Joachim
    Nakagawa, Kazuhiko
    Lorigan, Paul
    Pieters, Anne
    Sanchez, Teresa Kong
    Fairchild, Justin
    Spigel, David
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (31) : 3740 - +
  • [42] Survival and Toxicity After Cisplatin Plus Etoposide Versus Carboplatin Plus Etoposide for Extensive-Stage Small-Cell Lung Cancer in Elderly Patients
    Hatfield, Laura A.
    Huskamp, Haiden A.
    Lamont, Elizabeth B.
    JOURNAL OF ONCOLOGY PRACTICE, 2016, 12 (07) : 665 - +
  • [43] Taxotere plus cisplatin in previously untreated patients with extensive small cell lung cancer
    Gorbounova, V
    Orel, N
    Bychkov, M
    Naskhletashvili, D
    8TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2002, : 203 - 206
  • [44] A phase II trial of cisplatin and irinotecan alternating with doxorubicin, cyclophosphamide and etoposide in previously untreated patients with extensive-disease small-cell lung cancer
    Masahiro Tabata
    Katsuyuki Kiura
    Niro Okimoto
    Yoshihiko Segawa
    Tetsu Shinkai
    Toshiro Yonei
    Shoichi Kuyama
    Shingo Harita
    Katsuyuki Hotta
    Hiroshi Ueoka
    Mitsune Tanimoto
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 1 - 6
  • [45] Randomized controlled trial of lobaplatin plus etoposide vs. cisplatin plus etoposide as first-line therapy in patients with extensive-stage small cell lung cancer
    Cheng, Ying
    Fan, Yun
    Liu, Xiaoqing
    Liu, Yunpeng
    Liu, Jiwei
    Wang, Dong
    Yu, Yan
    Qin, Shukui
    Liu, Wei
    Huang, Cheng
    Zhang, Helong
    Liang, Jun
    Shi, Jianhua
    Sheng, Lijun
    Yu, Hao
    ONCOLOGY LETTERS, 2019, 17 (05) : 4701 - 4709
  • [46] A phase II trial of cisplatin and irinotecan alternating with doxorubicin, cyclophosphamide and etoposide in previously untreated patients with extensive-disease small-cell lung cancer
    Tabata, Masahiro
    Kiura, Katsuyuki
    Okimoto, Niro
    Segawa, Yoshihiko
    Shinkai, Tetsu
    Yonei, Toshiro
    Kuyama, Shoichi
    Harita, Shingo
    Hotta, Katsuyuki
    Ueoka, Hiroshi
    Tanimoto, Mitsune
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (01) : 1 - 6
  • [47] E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer
    Owonikoko, Taofeek K.
    Aisner, Joseph
    Wang, Xin Victoria
    Dahlberg, Suzanne E.
    Rubin, Eric H.
    Ramalingam, Suresh S.
    Gounder, Murugesan
    Rausch, Paul Gregory
    Axelrod, Rita S.
    Schiller, Joan H.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (01) : 171 - 180
  • [48] E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer
    Taofeek K. Owonikoko
    Joseph Aisner
    Xin Victoria Wang
    Suzanne E. Dahlberg
    Eric H. Rubin
    Suresh S. Ramalingam
    Murugesan Gounder
    Paul Gregory Rausch
    Rita S. Axelrod
    Joan H. Schiller
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 171 - 180
  • [49] Mathematical optimisation of the cisplatin plus etoposide combination for managing extensive-stage small-cell lung cancer patients
    C Faivre
    R El Cheikh
    D Barbolosi
    F Barlesi
    British Journal of Cancer, 2017, 116 : 344 - 348
  • [50] Phase II study of a 3-week schedule of irinotecan combined with cisplatin in previously untreated extensive-stage small-cell lung cancer
    Lee, Jeong Eun
    Park, Hee Sun
    Jung, Sung Soo
    Kim, Ju Ock
    Kim, Sun Young
    ONCOLOGY, 2007, 73 (1-2) : 76 - 80
12345